Cargando…
Effectiveness of COVID-19 Vaccines in Patients Under Maintenance Hemodialysis
BACKGROUND: Several published data on the dialysis population showed that antibody levels decreased after COVID-19 vaccinations in comparison to the overall population. We aimed to illustrate the persistence of humoral response after receiving second dose of the Pfizer or AstraZeneca vaccines in pat...
Autores principales: | Mahallawi, Waleed H, Ibrahim, Nadir A, Mumena, Walaa A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722686/ https://www.ncbi.nlm.nih.gov/pubmed/35002344 http://dx.doi.org/10.2147/RMHP.S345686 |
Ejemplares similares
-
Impaired humoral immune response to hepatitis B vaccine in patients on maintenance hemodialysis
por: Mahallawi, Waleed H., et al.
Publicado: (2023) -
Reactogenicity and Immunogenicity of the Pfizer and AstraZeneca COVID-19 Vaccines
por: Mahallawi, Waleed H., et al.
Publicado: (2021) -
Assessment of SARS-CoV-2 Anti-Spike IgG Antibody in Women and Children in Madinah, Saudi Arabia: A Single-Center Study
por: Mahallawi, Waleed H., et al.
Publicado: (2021) -
Unexpected Detection of Anti-SARS-CoV-2 Antibodies Before the Declaration of the COVID-19 Pandemic
por: Mahallawi, Waleed, et al.
Publicado: (2022) -
COVID-19 Vaccines in Patients with Maintenance Hemodialysis
por: Yen, Cheng-Chieh, et al.
Publicado: (2021)